Advanced Medical Emergency and Critical Care Center, Yamaguchi University Hospital, 1-1-1 Minamikogushi, Ube, Yamaguchi 755-8505, Japan.
BMC Infect Dis. 2009 Dec 21;9:209. doi: 10.1186/1471-2334-9-209.
The hypothalamo-pituitary-adrenal (HPA) axis modulates the inflammatory response during sepsis. Macrophage migration inhibitory factor (MIF), which counteracts the anti-inflammatory activity of glucocorticoid (GC), is one of the mediators of the development of inflammation. An inflammatory imbalance involving GC and MIF might be the cause or result of adrenal insufficiency. Our objective was to clarify the relationship between serum MIF and adrenal function in the HPA axis of sepsis patients using the adrenocorticotropic hormone (ACTH) stimulation test.
An observational study was performed in a university intensive care unit over a two-year period. Of 64 consecutive sepsis patients, 41 were enrolled. The enrolled patients underwent an ACTH stimulation test within 24 h of the diagnosis of severe sepsis or septic shock. Clinical and laboratory parameters, including serum MIF and cortisol, were measured.
Based on their responses to the ACTH stimulation test, the patients were divided into a normal adrenal response (NAR) group (n = 22) and an adrenal insufficiency (AI) group (n = 19). The AI group had significantly more septic shock patients and higher prothrombin time ratios, serum MIF, and baseline cortisol than did the NAR group (P < 0.05). Serum MIF correlated significantly with the SOFA (Sequential Organ Failure Assessment) score, prothrombin time ratio, and delta max cortisol, which is maximum increment of serum cortisol concentration after ACTH stimulation test (rs = 0.414, 0.355, and -0.49, respectively, P < 0.05). Serum MIF also correlated significantly with the delta max cortisol/albumin ratio (rs = -0.501, P = 0.001). Receiver operating characteristic curve analysis identified the threshold serum MIF concentration (19.5 ng/mL, P = 0.01) that segregated patients into the NAR and AI groups.
The inverse correlation between serum MIF and delta max cortisol or the delta max cortisol/albumin ratio suggests that high serum MIF reflects an insufficient adrenal response in the HPA axis. Serum MIF could be a valuable clinical marker of adrenal insufficiency in sepsis patients.
下丘脑-垂体-肾上腺(HPA)轴调节脓毒症时的炎症反应。巨噬细胞移动抑制因子(MIF)对抗糖皮质激素(GC)的抗炎活性,是炎症发展的介质之一。涉及 GC 和 MIF 的炎症失衡可能是肾上腺功能不全的原因或结果。我们的目的是使用促肾上腺皮质激素(ACTH)刺激试验阐明脓毒症患者 HPA 轴中血清 MIF 与肾上腺功能之间的关系。
在两年期间,在一所大学重症监护病房进行了一项观察性研究。在连续 64 例脓毒症患者中,纳入了 41 例患者。在诊断为严重脓毒症或感染性休克后 24 小时内,对纳入的患者进行了 ACTH 刺激试验。测量了临床和实验室参数,包括血清 MIF 和皮质醇。
根据对 ACTH 刺激试验的反应,患者分为正常肾上腺反应(NAR)组(n = 22)和肾上腺功能不全(AI)组(n = 19)。AI 组休克患者明显更多,凝血酶原时间比值、血清 MIF 和基线皮质醇均高于 NAR 组(P < 0.05)。血清 MIF 与 SOFA(序贯器官衰竭评估)评分、凝血酶原时间比值和 ACTH 刺激试验后血清皮质醇浓度的最大增量(delta max 皮质醇)显著相关(rs = 0.414、0.355 和 -0.49,P < 0.05)。血清 MIF 与 delta max 皮质醇/白蛋白比值也显著相关(rs = -0.501,P = 0.001)。受试者工作特征曲线分析确定了将患者分为 NAR 和 AI 组的血清 MIF 浓度阈值(19.5ng/ml,P = 0.01)。
血清 MIF 与 delta max 皮质醇或 delta max 皮质醇/白蛋白比值呈负相关,表明血清 MIF 升高反映了 HPA 轴中肾上腺反应不足。血清 MIF 可能是脓毒症患者肾上腺功能不全的有价值的临床标志物。